Citadel Advisors’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-29,900
| Closed | -$31.4K | – | 6070 |
|
2024
Q4 | $31.4K | Buy |
+29,900
| New | +$31.4K | ﹤0.01% | 5561 |
|
2024
Q2 | – | Sell |
-15,041
| Closed | -$20.8K | – | 6022 |
|
2024
Q1 | $20.8K | Sell |
15,041
-839
| -5% | -$1.16K | ﹤0.01% | 5541 |
|
2023
Q4 | $17.9K | Buy |
15,880
+5,442
| +52% | +$6.15K | ﹤0.01% | 5399 |
|
2023
Q3 | $15.8K | Buy |
+10,438
| New | +$15.8K | ﹤0.01% | 5360 |
|
2022
Q2 | – | Sell |
-18,516
| Closed | -$40K | – | 6095 |
|
2022
Q1 | $40K | Buy |
+18,516
| New | +$40K | ﹤0.01% | 5968 |
|